Home » Business » Moderna seeks FDA approval for booster vaccination for ages 18 and over

Moderna seeks FDA approval for booster vaccination for ages 18 and over


Moderna Inc. File a complaint with the U.S. Food and Drug Administration, or FDA for approval for the use of the COVID-19 vaccine of the company asbooster vaccine It is given to all adults aged 18 years and over using 50 micrograms, or half the usual dose, and given approximately 4 weeks after the second dose.

The FDA currently approves the booster vaccination for people who are immunocompromised, those 65 years of age or older, and those at high risk of developing serious illnesses or having frequent exposure to the virus.

.

Leave a Comment